Ignite Creation Date:
2025-12-24 @ 9:57 PM
Ignite Modification Date:
2026-02-06 @ 12:01 AM
Study NCT ID:
NCT06026332
Status:
RECRUITING
Last Update Posted:
2025-09-17
First Post:
2023-08-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
ADSTILADRIN Early Utilization and Outcomes in the Real World Setting
Sponsor:
Ferring Pharmaceuticals
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Bladder Cancer | View |